اثربخشی درمان‌های بیومدیکال بر نشانه‌ها و رضایتمندی خانواده‌ها در اختلال طیف اوتیسم

هدف پژوهش حاضر، بررسی اثربخشی درمان‌های بیومدیکال بر نشانه‌ها و رضایت‌مندی خانواده‌ها در اختلال طیف اوتیسم بود. روش پژوهش حاضر نیمه آزمایشی از نوع پیش‌آزمون-پس‌آزمون با گروه کنترل بود. جامعه آماری این پژوهش کودکان اوتیسم گروه‌ اوتیسم در فضای مجازی بودند که از این جامعه 30 نفر از کودکان اوتیسم 4 تا 12 ساله اوتیسم، 15 نفر در گروه آزمایش و 15 نفر در گروه کنترل به‌طور تصادفی گماشته شدند. برای جمع‌آوری داده‌های پژوهش، از چک‌لیست ارزیابی درمان اوتیسم (atec) استفاده شد. برنامه طی سه ماه توسط والدین و نظارت پژوهش‌گر انجام و داده های پژوهش با استفاده از روش تحلیل کوواریانس تجزیه‌وتحلیل شد. نتایج تحلیل کوواریانس نشان داد که درمان‌های بیومدیکال در کاهش نشانه‌ها در چک لیست ارزیابی درمان اوتیسم (atec) سبب رضایت‌مندی خانواده‌ها گردیده است. به نظر می‌رسد با تداوم این روش و دست‌یابی به مراحل بالاتر درمان، بتوان تغییرهای بیشتری در کاهش نشانه‌های اوتیسم و پیرو آن کاهش چالش‌های خانواده‌ها منجر به رضایت خانواده‌ها از درمان گردید.

the efficacy of biomedical treatments on the symptoms and satisfaction of families with autism spectrum disorder

abstractthe aim of this study was to investigate the effectiveness of biomedical treatments on the symptoms and satisfaction of families with autism spectrum disorder. the present research method was a semi-experimental pre-test-post-test type with a control group. the statistical population of this research was the autistic children of the autism group in virtual space, from which thirty autistic children aged four to twelve with autism, fifteen in the experimental group and fifteen in the control group were randomly assigned. the autism treatment evaluation checklist (atec) was used to collect research data. the program was conducted in three months by parents and the supervision of the researcher, and the research data was analyzed using the covariance analysis method. the results of covariance analysis showed that biomedical treatments in reducing the symptoms in the autism treatment evaluation checklist (atec) have caused families to be satisfied. it seems that with the continuation of this method and reaching higher stages of treatment, more changes can be made in reducing the symptoms of autism and following it, reducing the challenges of the families, leading to the families’ satisfaction with the treatment.keywords: biomedical treatments, family satisfaction, autism spectrum disorder.   extended abstractintroductionautism is a complex neurodevelopmental genetics that is caused by a combination of environmental factors. in all areas of the child’s development, it is affected and behaviorally, it is limited by social damage, indirect social connection and definition (chast and leboer, 2022). the personal and financial cost of an autistic person in families is very high (hoffer et al., 2022). so far, only behavioral therapies have been the mainstay of managing this disorder (pitson et al., 2020). the absence of effective treatments for the neurodevelopmental disorder of autism is significant (aishwarya et al., 2022). the fact that autism treatment is unproven is itself a source of family dissatisfaction and requires an urgent need to focus on the mental health of the family and create consistency in the care of the autistic individual (lerner, white and mcpartland, 2022). psychiatrically, there are still no approved medications for the main symptoms of the disorder, such as social and communication problems, repetitive behaviors, and secondary symptoms, such as irritability and aggression (nirenius et al., 2022). parents reported that supplements and diet were the most helpful treatments in reducing symptoms compared to other treatments they had used to treat autism (adams et al., 2018). since environmental chemicals and toxins are also